GeneDx Holdings Corp. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3ecac109-5700-4edf-bb4c-775d388de280/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $427.5M | 2025-01-01 – 2025-12-31 | evidence 0001818331-26-000015 |
| FY 2024 | $305.4M | 2024-01-01 – 2024-12-31 | evidence 0001818331-25-000021 |
| FY 2023 | $202.6M | 2023-01-01 – 2023-12-31 | evidence 0001818331-24-000008 |
| FY 2022 | $234.7M | 2022-01-01 – 2022-12-31 | evidence 0001818331-23-000024 |
| FY 2021 | $212.2M | 2021-01-01 – 2021-12-31 | evidence 0001818331-22-000037 |
| FY 2020 | $179.3M | 2020-01-01 – 2020-12-31 | evidence 0001818331-22-000037 |
| FY 2019 | $196.2M | 2019-01-01 – 2019-12-31 | evidence 0001818331-22-000037 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GeneDx Holdings Corp. — all facts · Net Income · Operating Income